EVP and Pres-Pharm, Consumer W Prem Shah Sells 29,473 Shares of CVS Health Corp
Prem Shah, EVP and Pres-Pharm, Consumer W of CVS Health Corp (NYSE:CVS), has sold 29,473 shares of the company on February 16, 2024, according to a recent SEC Filing. The transaction was executed at an average price of $76.95 per share, resulting in a total value of $2,268,502.35.
CVS Health Corp is a healthcare innovation company with a purpose to help people on their path to better health. The company operates through a unique combination of businesses including a pharmacy benefit manager, a nationwide network of pharmacies, and long-term care pharmacies, complemented by health care benefits and community-based health services. CVS Health Corp's offerings across the healthcare spectrum serve an estimated 38 million people.
Over the past year, the insider has sold a total of 29,473 shares and has not made any purchases. The recent sale by Prem Shah represents a continuation of this selling trend.
The insider transaction history for CVS Health Corp indicates a balanced activity from insiders. There have been 2 insider buys and 2 insider sells over the past year.
On the valuation front, CVS Health Corp's shares were trading at $76.95 on the day of the insider's sale, giving the company a market cap of $97.03 billion. The price-earnings ratio stands at 11.93, which is below the industry median of 18.36 and also below the company's historical median price-earnings ratio.
The stock's price-to-GF-Value ratio is 0.7, with a GF Value of $110.65, indicating that CVS Health Corp is significantly undervalued according to GuruFocus's intrinsic value estimate. The GF Value is calculated based on historical trading multiples, a GuruFocus adjustment factor, and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
